*University of Southampton, Royal South Hants Hospital, Southampton SO14 0YG, email: dgk{at}soton.ac.uk
University of Southampton
University of Newcastle, Royal Victoria Infirmary, Newcastle
None. National Health Service research and development support funding.
|
|
|---|
Health promotion campaigns using current terminology have had limited success in reducing stigma to schizophrenia. Terminology and subgroups based on historical precedent, clinical experience and psychosocial research have been developed to provide an alternative to existing terminology, and the attitudes to schizophrenia and alternative terminology of a sample of medical students (n=241) were compared.
RESULTS
Overall attitudes were significantly less negative with the alternatives. The students were less negative about the potential for recovery in relation to all the subgroups than for schizophrenia. Concerns about dangerousness were also less prominent with the exception of the drug-related group.
CLINICAL IMPLICATIONS
Subgroups and alternative terminology should be further explored in programmes to destigmatise schizophrenia.
|
|
|---|
An alternative approach is to associate schizophrenia with evidence from psychosocial research which has found that trauma (Read et al, 2003), hallucinogenic drug use (Hall, 2006) and stress-sensitivity (Myin-Germeys et al, 2005) are significant risk factors. Approaches using cognitive therapy have found such associations valuable in directing formulation-based therapeutic interventions (Kingdon & Turkington, 2005). Using such associations has also proved meaningful and more acceptable to service users and carers who dislike the very term schizophrenia (Kingdon et al, 2008) and are proposing alternatives (Teskey, 2006). Renaming schizophrenia is controversial and concern has been expressed that it would not address the core problem that is the publics ignorance and fear (Lieberman & First, 2007). Nevertheless, attention to naming cannot be dismissed - the public relations industry devotes substantial resources to the importance of presentation of services and products (Kingdon et al, 2007).
Describing more precisely Bleulers group of schizophrenias (Bleuler, 1911) would allow research, training and terminology to be tailored to each of them. Kraepelin (1919) made an attempt to do this - he famously delineated manic depressive insanity from dementia praecox but also differentiated it from paranoid states where behaviour was only abnormal in so far as it was the outcome of delusions. He also distinguished dementia praecox from hysteria but then reclaimed those in whom hallucinations were persistent as he believed this gave decisive evidence for dementia praecox. Schneiders emphasis on defining schizophrenia based on the nature of symptoms rather than their content (Schneider, 1959) initially led to a tighter definition of schizophrenia. However, first-rank symptoms have proved to be less specific than initially hoped (Carpenter et al, 1973) - for example, they have been demonstrated to occur in association with trauma (Ross & Joshi, 1992) and in individuals whose initial psychotic experience was directly from the effects of stimulant and hallucinogenic drugs. The inclusion of this group under the schizophrenia rubric became of increasing importance from the 1960s onwards, leading to a substantial broadening of this diagnostic category.
Thus, a combination of clinical observation, psychosocial research and historical precedent has contributed to the delineation of four possible subgroups of schizophrenia. Kraepelins dementia praecox has survived in classification systems as disorganised schizophrenia (DSM-IV), nuclear schizophrenia and hebephrenia. This has been refined further as the deficit state (Kirkpatrick et al, 2001), renamed for use with patients as stress-sensitivity psychosis. Kraepelins inclusion of hallucinating hysteria in dementia praecox has been reversed and, reinforced by the evidence of childhood trauma as a factor in some - particularly female - patients, has become traumatic psychosis. Paranoid states, variously described as late-onset paranoia, paranoid schizophrenia and delusional disorder - where systematised delusions develop in mature individuals experiencing stressful circumstances - has led to a revival of Wernickes term anxiety psychosis (Healy, 2002). Finally, drug-related psychosis which did not exist when the group of schizophrenias was originally described, is recognised in its own right.
These terms have been found to be acceptable to both patients and clinical staff (Kingdon et al, 2008) and this study was developed to explore whether they might be less stigmatising than the term schizophrenia itself. Medical students were recruited as being readily accessible to the researchers and able to readily comprehend the requirements of the study. Another reason was that doctors have a seminal role in combating stigmatisation but their attitudes to psychiatry (Rajagopal et al, 2004) and people with mental health problems (Byrne, 1999) remain quite negative, which may affect their response to patients physical and psychological care (Thornicroft, 2006). We sought to test the hypothesis that the use of terminology based on psychosocial subgroups would lead to differences between these groups and schizophrenia, and that negative attitudes in respondents would be reduced.
|
|
|---|
The students were also given brief descriptions of the psychosocial subgroups (Appendix) and asked to rate the individual groups against the same characteristics. Respondents were regarded as having a negative opinion if they endorsed either of the two points on the five-point scale on the negative side of its mid-point.
Data measured on a continuous scale were presented with mean, standard deviation and 95% confidence intervals. Normally distributed continuous data were analysed using one-way analysis of variance (ANOVA) and t-tests. Where data was skewed and non-normally distributed, non-parametric techniques (Kruskal-Wallis test and Mann-Whitney U-test) were applied. Categorical data were presented in percentages and association between categorical variables was assessed with the use of chi-squared test and where expected frequency were below five then the Fishers exact test was used. Statistical significant was assessed if P<0.05 and all analysis was conducted with the use of a statistical software SPSS version 14 for Windows.
|
|
|---|
|
View this table: [in a new window] |
Table 1. Respondents holding negative opinions about schizophrenia
|
The distribution of student attitudes towards schizophrenia and the subgroups markedly differed (Fig. 1). For schizophrenia, the distribution was normal. The drug-related group was similar but flattened and shifted towards higher values, whereas the other groups had a skewed distribution towards a lack of negative attitudes.
![]() View larger version (29K): [in a new window] [as a PowerPoint slide] |
Fig. 1. Distribution of negative attitudes.
|
|
View this table: [in a new window] |
Table 2. Negative attitudes to schizophrenia and subgroups
|
![]() View larger version (17K): [in a new window] [as a PowerPoint slide] |
Fig. 2. Negative opinions of medical students to schizophrenia and psychosocial
subgroups.
|
|
|
|---|
The study does have significant limitations. As an intervention to change attitudes, a randomised controlled approach would be more rigorous: the terms were not presented in a randomised way and this might have influenced the outcome. Also, as with many such health promotion studies, this investigation has been into declared attitudes and further work is needed to see if this is reflected in behaviour change and in the wider population where attitudes are more negative (Crisp, 2004) than in medical students.
|
|
|---|
Drug-related psychosis
My problems started after I had taken speed (amphetamines), LSD, cocaine or a lot of cannabis. After that I started to get some problems and received treatment. The problems continued or came back after settling after the first time this happened. Eventually these problems were happening even when I did not take drugs.
Anxiety psychosis
When I first received treatment for my problems, I had been having some hassle, stress, and so on, but had become convinced that there was a particular reason behind it all. Unfortunately, other people did not agree with me.
Traumatic psychosis
My problems go back quite a way - maybe even as far as my childhood or soon after - and seem to have something to do with some very unpleasant experiences that I had. Now I seem to get unpleasant voices and maybe also visions - sometimes to do with these experiences.
Stress-sensitivity psychosis
My problems began over a period of a few months or even a year or two. I became quite sensitive to stress which gradually led to interference with what I was doing. This led to increasing confusion and worry and eventually I received treatment. It was or has been difficult to get going again properly - however hard I try.
|
|
|---|
This article has been cited by other articles:
![]() |
Cognitive behavioural therapy for schizophrenia DTB, January 1, 2010; 48(1): 6 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kingdon, Y. Kinoshita, P. Hammersley, L. Hansen, S. Rathod, F. Naeem, and D. Turkington Time to change concepts and terminology The British Journal of Psychiatry, June 1, 2009; 194(6): 569 - 570. [Full Text] [PDF] |
||||
Read all eLetters
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||